Latest AL-S Pharma News & Updates

See the latest news and media coverage for AL-S Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
AL-S Pharma

Biotechnology company developing ALS therapies

al-spharma.com
Founded year
2016
Company type
Private company
Number of employees
10–50

Last updated

Latest news about AL-S Pharma

In short: AL-S Pharma reported positive Phase 2 results for its ALS drug AP-101 and announced plans to begin a Phase 3 clinical trial.

Company announcements

  • AL-S Pharma

    AL-S Pharma presents Phase 2 results for AP-101

    CMO Angela Genge shares safety, biomarker, and clinical data from 48-week trial in NEALS webinar on May 15. Prepares for Phase 3 trial in Q1 2027.

  • AL-S Pharma

    AL-S Pharma discusses AP-101 Phase 2 data

    Chief Medical Officer Angela Genge highlights survival improvements and biomarker reductions in ALS patients. Next steps follow Phase 2 success.

  • AL-S Pharma

    AL-S Pharma announces additional Phase 2 data for AP-101

    Data demonstrate disease modification and prolonged survival in ALS, supported by biomarker reductions. Preparations advance for Phase 3 trial in late 2026.

  • AL-S Pharma

    AL-S Pharma shares Phase 2 data for AP-101 at AD/PD

    Dr. Angela Genge presents on March 19, 2026, in Copenhagen. AP-101 targets misfolded SOD1 in ALS patients.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about AL-S Pharma

Track AL-S Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

AL-S Pharma competitors & trending companies

Browse news for competitors to AL-S Pharma and other trending companies.